W. Bradford Smith
Equibles does not estimate personal net worth.
About W. Bradford Smith
Earlier roles on record: CFO at Q32 Bio Inc. (QTTB) until November 17, 2023. Q32 Bio Inc. reported in an 8-K filed November 16, 2023 that W. Bradford Smith was terminated as Chief Financial and Business Officer and Treasurer, effective November 17, 2023. The proxy statement of Q32 Bio Inc. reports total compensation of $994,251 for W. Bradford Smith in fiscal 2022, including a base salary of $460,900. Disclosed compensation is on record for 4 fiscal years.
“On November 16, 2023, subject to the execution of the Merger Agreement, the Board terminated the employment of each of Albert Seymour, Ph.D. and W. Bradford Smith, effective as of November 17, 2023.”
Affiliation history
-
Q32 Bio Inc. (QTTB)
Proxy statement
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
-
Start not stated–2023-11-17
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Q32 Bio Inc. (QTTB) | Chief Financial and Business Officer and Treasurer | $460,900 | $994,251 |
| 2021 | Q32 Bio Inc. (QTTB) | Chief Financial and Business Officer and Treasurer | $445,300 | $2,047,779 |
| 2020 | Q32 Bio Inc. (QTTB) | Chief Financial Officer | $406,700 | $582,380 |
| 2019 | Q32 Bio Inc. (QTTB) | Chief Financial Officer | $384,200 | $1,860,296 |